Harbour BioMed Appoints Mr. Weihao Xu as Chief Strategy Officer
Harbour BioMed s pleased to announce the appointment of Mr. Weihao Xu as Chief Strategy Officer (CSO), who will base in San Francisco. Mr. Xu will be the Global Head of Business Development and Corporate Development, responsible for developing and executing strategy for partnership and corporate investment, building innovation capabilities as......
